<DOC>
	<DOCNO>NCT00435019</DOCNO>
	<brief_summary>This trial conduct Europe . The aim research compare efficacy safety treatment NPH insulin insulin detemir . You treat either insulin detemir NPH insulin twice daily basal insulin . Additionally receive insulin aspart bolus insulin</brief_summary>
	<brief_title>Comparison NPH Insulin Insulin Detemir Children Adolescents With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Insulin detemir naive Type 1 diabetes least 12 month HbA1c lesser equal 11.0 % Significant concomitant disease</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>